Case Study: How AstraZeneca evolved its digital supply chainGiving people the tools to do their job more effectively has boosted productivity at AstraZeneca. The company says Share XCase Study: How AstraZeneca evolved its digital supply chainhttps://pharmaphorum.com/debates-insight-sales-marketing/case-study-how-astrazeneca-evolved-its-digital-supply-chain/
Case Study: How Shire improved its time-to-marketAdopting an end-to-end commercial content management system has allowed one of the world’s biggest pharmaceutical companies to be Share XCase Study: How Shire improved its time-to-markethttps://pharmaphorum.com/debates-insight-sales-marketing/case-study-how-shire-improved-its-time-to-market/
Overcoming the demands of digital content: Is your pharma content approval system ready for the modern age?Over the last ten years the increase in use of digital content and communication throughout pharma has been Share XOvercoming the demands of digital content: Is your pharma content approval system ready for the modern age?https://pharmaphorum.com/debates-insight-sales-marketing/overcoming-the-demands-of-digital-content-is-your-pharma-content-approval-system-ready-for-the-modern-age/
Navigating new frontiers: Ways to find space in the future RA marketOverview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
Acting on the moments that matter to build a brandAll too often pharmaceutical marketing orthodoxy says to focus on just one area – a product’s launch, in Share XActing on the moments that matter to build a brandhttps://pharmaphorum.com/sales-marketing/acting-on-the-moments-that-matter-to-build-a-brand/
Cost concerns with the new NHS pricing schemeA new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded Share XCost concerns with the new NHS pricing schemehttps://pharmaphorum.com/views-analysis-market-access/cost-concerns-with-the-new-nhs-pricing-scheme/
The 2nd Life Sciences Sector Deal and the NHS 10 Year PlanOverview Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK Share XThe 2nd Life Sciences Sector Deal and the NHS 10 Year Planhttps://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/
Designing behavioural science-based patient support programmesWe all exhibit behaviours that are, at times, irrational, and this presents a major challenge for pharmaceutical companies Share XDesigning behavioural science-based patient support programmeshttps://pharmaphorum.com/sales-marketing/designing-behavioural-science-based-patient-support-programmes/
New support group will help families adapt to LHONPersonal experience of helping her son juggle sight loss and adolescence means Francesca Müeller understands all too well Share XNew support group will help families adapt to LHONhttps://pharmaphorum.com/disease-spotlight/lhon-main/new-support-group-will-help-families-adapt-to-lhon/
